BAG3 has been shown to be overexpressed in tumour cell lines and solid tumours including small cell lung carcinomas, glioblastomas and pancreatic adenocarcinomas where it’s overexpression is associated with poor survival [14–16]. This evidence concerns the gene BAG3 and pancreatic adenocarcinoma.